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People’s Republic of China
S U M M A R Y
Brucellosis is a worldwide re-emerging zoonotic disease. It remains a serious public health problem in
many developing countries including China. This review summarizes the epidemiological character-
istics, morbidity, and endemic distributions of human brucellosis in the People’s Republic of China for
the period 2005–2010. From 2005 to 2010, the incidence of human brucellosis rose substantially in
China, especially in the provinces of Inner Mongolia, Shanxi3, Heilongjiang, Hebei, Jilin, and Shanxi1.
Meanwhile human brucellosis increased gradually in some southern provinces, such as Henan,
Guangdong, and Fujian. Due to the rapid expansion of human brucellosis in China, surveillance and
prevention of this disease has been greatly challenged.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Brucellosis, especially that caused by Brucella melitensis, is an
old disease and yet is the most common zoonotic disease
worldwide, with an annual occurrence of more than 500 000
cases and prevalence rates exceeding 10 cases per 100 000
population in some countries.1,2 Humans are infected by this
pathogen mainly through contact with infected animals or by
consuming unpasteurized and unboiled milk or fresh cheese.1 On
entry into the human, the pathogens multiply inside phagocytic
cells and eventually cause clinical symptoms, such as undulant
fever, abortion, orchitis, spondylitis, arthritis, endocarditis, en-
cephalitis, and asthenia. Brucellosis is listed as a Class II reportable
disease by the Centers for Disease Control and Prevention (CDC) of
the People’s Republic of China and as a Class II key disease by the
Disease Prevention and Control of Livestock and Poultry in China.3
More importantly it is classiﬁed by the CDC as a class B bioterrorist
agent, as Brucella spp can easily be aerosolized, and thus could be
used to develop a biological weapon. Of note, the geographical
distribution of brucellosis changes dynamically, with new foci
emerging or re-emerging worldwide. Thus, as a re-emerging
infectious disease, human brucellosis requires robust and en-
hanced surveillance in many areas.4* Corresponding author. Tel.: +86 0835 2885302; fax: +86 0835 2885302.
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http://dx.doi.org/10.1016/j.ijid.2012.12.030In China, human brucellosis was ﬁrst reported in 1905.5 Serial
investigations of the epidemiological characteristics of brucellosis
have been carried out since 1950. The incidence of brucellosis was
quite severe in animals and humans before the 1980s and later
declined. From 1990 to 2001, the incidence of animal brucellosis
remained unchanged, but the incidence of human brucellosis
increased greatly.3 In 2008, 21 surveillance points for animal and
human brucellosis were established in 19 provinces in order to
tightly monitor/prevent the onset of disease.6 Several vaccines
have been developed for disease prevention and control, such as
Brucella suis S2, Brucella abortus S19, and B. melitensis M5.
Remarkably China is one of the few countries where the vaccines
have been used to prevent human brucellosis (B. abortus 104 M).3
However, the epidemiology of the human brucellosis situation
became more severe during 2005–2010.
In this paper, the epidemiological characteristics, morbidity,
and endemic distributions of human brucellosis were analyzed for
31 provinces with high incidence rates of brucellosis, for the period
2005–2010, in accordance with the criteria of the CDC of the
People’s Republic of China.
2. Materials and methods
2.1. Data source
The data in this study were extracted from medical cases
occurring during 2005–2010. The number of human brucellosisses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Reported cases and annual incidence (n/100 000 population) of human
brucellosis in the People’s Republic of China during 2005–2010.
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Republic of China and the CDC of the People’s Republic of China.
Any suspected or conﬁrmed case of brucellosis in China must be
reported to the Chinese CDC through the National Notiﬁable
Disease Surveillance System. The report of human cases must be
accompanied by clinical signs and conﬁrmed by serologic test or
isolation of the organism, in accordance with the case deﬁnition of
the World Health Organization.7,8
2.2. Education campaigns, surveillance points, and intervention pilot
In China, education campaigns to reduce the risk and
consequences of human brucellosis disease have been designed
and launched by the CDC of the People’s Republic of China and
executed by local provincial governments and CDCs. The National
Brucellosis Surveillance Points for Human and Animal Brucellosis
and the National Brucellosis Intervention Pilot County are the two
major programs.6,9 The two programs include seven aspects: (1)
strengthening the supervising responsibility of local governments
and departments; (2) improving the preventive treatment in
human brucellosis and the professional skills of the experts; (3)
monitoring of human brucellosis epidemics and improving the
reporting system of outbreaks to the CDC; (4) executing the
prevention of animal brucellosis; (5) epidemic situations must be
investigated by the joint forces of the Ministry of Health and the
Ministry of Agriculture; (6) provincial CDCs supervise the control
and prevention of human and animal brucellosis; (7) promoting
education campaigns for health awareness and increasing the
knowledge of the population with regard to the prevention of
human and animal brucellosis.
2.3. Data analysis
The statistics in this study were analyzed using SPSS software
(version 17.0). A linear regression model was used to assess the
incidence rate of the time trend in each province during 2005–
2010,10 year (X) as the independent variable and Y as the
dependent variable. Y is the incidence rate of the natural logarithm
(as Y = ln(r)). p-Values of <0.05 were considered statistically
signiﬁcant.
3. Results
3.1. Overview of human brucellosis incidence in China
As shown in Figure 1, the annual reported cases of human
brucellosis showed an upward trend from 2005 to 2009, and a
slight decline in 2010. In 2005, a total of 18 416 cases were
reported. Thereafter a steep increase in human brucellosis cases
was reported during 2008–2009. The peak disease incidence
occurred in 2009, with 35 816 cases reported, almost double the
cases from 2005. In 2010 there was a slight decline (33 772 cases),
but the number of cases remained higher than the annual reports
for 2005–2007. At the same time, the annual incidence rate of the
disease varied from 1.41 to 2.7 per 100 000 population during the
study period (Figure 1). The rate in 2005 was 1.41 cases per 100 000
population, but showed an upward trend in the following years. In
2009 and 2010, the rate rose to 2.7 and 2.56/100 000, respectively.
Compared to the rate in 2005, the rate had tripled in 2009 and
2010, showing a dramatic change over the 6 years.
3.2. Analysis of human brucellosis in 31 provinces of China
As shown in Table 1, 18 provinces reported new cases of human
brucellosis in 2005, but the epidemic regions expanded to 30provinces of P.R. China (except for Hong Kong, Macao, Taiwan, and
Jiangxi) over the 6 years.
During 2005–2010, a total of 155 979 new cases were reported
in China. Inner Mongolia, Shanxi3, Heilongjiang, Hebei, Jilin, and
Shanxi1 were the top six provinces with the most cases. Inner
Mongolia had 69 092 reported cases, or 50% of all the reported
cases in China. As shown in Table 1, Inner Mongolia had the most
reported cases in 2009 and 2010 (16 551 and 16 224 cases,
respectively). The annual incidence rate varied from 33.17 to 68.33
per 100 000 population during the study period, which is much
higher than in the other provinces (p < 0.01). In Shanxi3 Province,
the number of reported cases increased sharply from 2005 to 2008.
The annual incidence rate rose from 6.92 to 14.17 per 100 000
population during 2005–2008, and declined slightly during 2009–
2010 (13.91 and 10.88 per 100 000 population). In contrast to
Shanxi3 Province, the reported number of cases in Heilongjiang
Province showed a decrease from 2005 to 2007. However, the
reported cases increased 1.93 times in 2010 when compared to
2007. In Hebei Province, the number of reported cases kept an
upward trend during 2005–2009, rising from 1181 to 3218.
Compared to other provinces, the number of reported cases in Jilin
Province increased greatly in recent years. The number of cases
increased markedly from 2007 to 2009, with 12 times the annual
incidence: an increase from 1.92 per 100 000 population in 2005 to
12.60 per 100 000 population in 2009 (p < 0.01). In Shanxi1
Province, there was an increase in reported cases and then a
decline (483 cases in 2005 and 1034 cases in 2008, then 911 and
525 cases in 2009 and 2010, respectively).
Moreover, reported cases and annual incidence rates in Henan,
Xinjiang, Ningxia, Gansu, Guangdong, and Fujian provinces all
showed an increasing trend during the study period (p < 0.05)
(Table 1). Especially in Henan and Ningxia provinces, more cases
were reported in 2010 (791 and 207 cases, respectively). In Henan,
the annual incidence rate showed a signiﬁcant upward trend in the
period 2005–2010 (p < 0.01). The annual incidence in Ningxia rose
from 0.44 to 3.27 per 100 000 population in the period of 2005–
2010 (p < 0.05). Remarkably in 2010, the very ﬁrst case of
brucellosis was reported in Hainan Province since the founding
of new China in 1949.
The regional distribution of the lowest and highest annual
reported cases were applied to analyze the geographic distribution
of human brucellosis in China (Figure 2, A and B). From the regional
distribution map, it is clearly demonstrated that the areas with
heavy brucellosis epidemics are mainly located in the northern
provinces of China, particularly those in the northeast and
Table 1
Reported cases and annual incidence rate (/100 000 population) of human brucellosis in 31 provinces in China during 2005–2010
Province 2005 2006 2007 2008 2009 2010 p-Value
Inner Mongolia 8663 (36.31) 7951 (33.17) 8598 (35.75) 11 105 (46.01) 16 551 (68.33) 16 224 (65.63) 0.14
Shanxi3 2320 (6.92) 3452 (10.23) 4447 (13.11) 4834 (14.17) 4768 (13.91) 3888 (10.88) 0.169
Heilongjiang 3943 (10.33) 2949 (7.71) 2523 (6.60) 3670 (9.59) 4724 (12.35) 4861 (12.68) 0.227
Hebei 1181 (1.73) 2334 (3.38) 2567 (3.70) 3173 (4.54) 3218 (4.57) 2503 (3.48) 0.129
Jilin 521 (1.92) 599 (2.20) 985 (3.61) 2139 (7.82) 3452 (12.60) 2905 (10.58) 0.003
Shanxi1 483 (1.30) 636 (1.70) 793 (2.12) 1034 (2.75) 911 (2.42) 525 (1.41) 0.559
Liaoning 604 (1.43) 439 (1.03) 374 (0.87) 484 (1.12) 509 (1.18) 606 (1.39) 0.786
Henan 141 (0.15) 194 (0.21) 337 (0.36) 593 (0.63) 703 (0.74) 791 (0.84) 0.001
Xinjiang 297 (1.48) 263 (1.29) 326 (1.56) 395 (1.86) 441 (2.04) 797 (3.65) 0.021
Shandong 163 (0.18) 108 (0.12) 142 (0.15) 135 (0.14) 156 (0.16) 222 (0.23) 0.262
Ningxia 26 (0.44) 7 (0.12) 32 (0.52) 94 (1.52) 157 (2.51) 207 (3.27) 0.027
Zhejiang 25 (0.05) 24 (0.05) 13 (0.03) 34 (0.07) 38 (0.07) 31 (0.06) 0.436
Gansu 5 (0.02) 6 (0.02) 8 (0.03) 6 (0.02) 84 (0.32) 46 (0.18) 0.045
Guangdong 3 (0.00) 14 (0.02) 15 (0.02) 18 (0.02) 27 (0.03) 35 (0.03) 0.019
Tianjin 11 (0.11) 4 (0.04) 8 (0.07) 14 (0.12) 24 (0.20) 56 (0.43) 0.058
Beijing 8 (0.05) 9 (0.06) 4 (0.02) 12 (0.07) 17 (0.10) 29 (0.15) 0.129
Tibet 21 (0.76) 8 (0.28) 2 (0.07) 2 (0.07) 1 (0.03) 0 (0.00) 0.010
Yunnan 0 (0.00) 1 (0.00) 1 (0.00) 10 (0.02) 12 (0.03) 8 (0.02) 0.082
Jiangsu 0 (0.00) 5 (0.01) 3 (0.00) 5 (0.01) 6 (0.01) 5 (0.01) 0.542
Anhui 0 (0.00) 2 (0.00) 1 (0.00) 2 (0.00) 7 (0.01) 4 (0.01) 0.175
Fujian 0 (0.00) 1 (0.00) 2 (0.01) 4 (0.01) 3 (0.01) 5 (0.01) 0.039
Sichuan 0 (0.00) 6 (0.01) 0 (0.00) 1 (0.00) 1 (0.00) 2 (0.00) 0.355
Qinghai 1 (0.02) 0 (0.00) 6 (0.11) 0 (0.00) 0 (0.00) 3 (0.05) 0.668
Shanghai 0 (0.00) 0 (0.00) 5 (0.03) 2 (0.01) 0 (0.00) 0 (0.00) -
Guangxi 0 (0.00) 0 (0.00) 2 (0.00) 0 (0.00) 1 (0.00) 3 (0.01) 0.874
Guizhou 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 3 (0.01) 1 (0.00) -
Chongqing 0 (0.00) 1 (0.00) 0 (0.00) 0 (0.00) 2 (0.01) 0 (0.00) -
Hubei 0 (0.00) 0 (0.00) 1 (0.00) 0 (0.00) 0 (0.00) 5 (0.01) -
Hunan 0 (0.00) 0 (0.00) 0 (0.00) 1 (0.00) 0 (0.00) 9 (0.01) -
Hainan 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1 (0.00) -
Jiangxi 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) -
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frequent livestock product transactions.3 Figure 2 shows that the
epidemics in the old regions were still not effectively controlled
and that they expanded into southern regions of China. During
2005–2010, the incidence of brucellosis showed increasing
tendencies in Henan, Guangdong, and Fujian provinces
(p < 0.05). These data indicate that human brucellosis is likely
to expand from the epidemic regions to the non-epidemic
provinces.
4. Discussion
At present, 15 of the total 19 biotypes of Brucella have been
isolated in China, including B. melitensis (biotypes 1, 2, and 3), B.
abortus (biotypes 1–7 and 9), B. suis (biotypes 1 and 3), B. ovis, and
B. canis.3,11 From 2005 to 2006, of the more than 100 strains
isolated, B. melitensis was the predominant strain.12 In 2009, 75
strains were isolated in 15 provinces, of which 68 strains were B.
melitensis biotype 3, accounting for 90.7%, indicating that the major
epidemic strain in China was B. melitensis biotype 3.12 Recent
studies have implied that strains isolated from southern China had
the same MLVA-16 genotype (multilocus variable number tandem
repeat analysis 16 loci panel) as those from northern and eastern
China, indicating that brucellosis in the south may have originated
from the importation of animals from elsewhere in China.13
Before the 1980s, the epidemic regions of human brucellosis
were distributed in Inner Mongolia, Xinjiang, Tibet, Qinghai,
Ningxia, and other scattered epidemic provinces.3 In our study we
found that in the period 2005–2010, the human brucellosis
epidemic remained in the northeastern provinces (i.e., Inner
Mongolia and northern China) where animal husbandry has
developed. The rising incidence rate could have a potential
correlation to the trans-boundary transfer of animal brucellosis
in the region of Inner Mongolia from the neighboring hyperen-
demic Mongolia, which has been described as the country with thesecond highest incidence worldwide.2 The increase in animal
feeding, lack of immunization and animal quarantine, and frequent
trading are the leading risk factors for the high incidence rate.
Moreover, a complete monitoring system would be able to report
the incidence data in an unbiased manner. Therefore, it is of
importance for the local and provincial CDC to control/prevent
human brucellosis in the most epidemic cities.
Human brucellosis cases have mainly appeared in particular
key cities in endemic areas of China; Hulunbeir and Xilinguole in
Inner Mongolia, Datong in Shanxi3, Qiqihaer in Heilongjiang,
Zhangjiakou in Hebei, Songyuan in Jilin, and Yulin in Shanxi1
showed the highest human brucellosis incidence.8,14,15 Among
those cities, the number of reported cases in Hulunbeir reached a
record high of 2798 cases in 2005.8,14 In Songyuan, the number of
newly reported cases has increased continuously in recent years. In
2008, 1019 new cases were reported, which is twice the reported
number in 2005.15
In China, a national brucellosis eradication program has been
implemented since the 1990s. There are 21 human brucellosis
surveillance points and 10 animal surveillance points in China,
which monitor brucellosis outbreaks in time.6 Meanwhile, a
project named the National Brucellosis Intervention Pilot County
was also set up in 2005 to survey and prevent animal and human
brucellosis.9 Human brucellosis in most provinces was effectively
controlled due to better surveillance and prevention rules.
Although many measures based on the control programs for
brucellosis have been set up (including slaughtering infected
animals), the brucellosis-positive rate in animals has increased
signiﬁcantly. In 2008, 3.5 million cattle (dairy cattle 3.24 million)
were examined by serological tests and the positive rate was 0.64%
(0.58% dairy cattle); 10 999 positive cattle were slaughtered
(including dairy cattle 10 362). Sheep were also tested; the positive
rate was 0.84% for 4.74 million sheep, and 11 329 positive sheep
were killed.12 In 2009, of a total of 41 736 sheep, 626 were found to
be seropositive (positive rate = 1.49%); a total of 62 843 cattle were
Figure 2. Geographic distribution by annual incidence of human brucellosis in (A)
2005 and (B) 2009, People’s Republic of China.
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1.36%).12 The high brucellosis-positive rate in animals could be one
of the factors that has led to the increase in human brucellosis
cases in recent years.
Our study is limited by several unavoidable factors. First, since
the data derived from 31 provinces were aggregated data, the
quality of the data cannot be controlled. Second, the data reported
directly by the disease reporting system of the provinces is only
part of the actual incidence of human brucellosis. Third, themisdiagnosis rate is high in low-incidence areas and the under-
reporting phenomenon is serious. Nevertheless, the data analyzed
in this study are still able to reﬂect the current trend in the
incidence of human brucellosis in China. Our investigation is
potentially helpful to establish strategies for the prevention and
surveillance of human brucellosis in China and in other countries.
In conclusion, our data show that human brucellosis occurred
mainly around the border with Inner Mongolia (except Xinjiang
Province), and brucellosis outbreak points also increased signiﬁ-
cantly during 2005–2010. At the same time, endemic regions
gradually spread to some southern provinces, including Henan,
Guangdong, and Fujian. More non-epidemic provinces have
become epidemic, which implies that the epidemic regions of
brucellosis had diversiﬁcation. It is necessary to develop better
strategies for brucellosis prevention and control in the near future.
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